BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38029326)

  • 1. Erratum to: Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
    BJS Open; 2023 Nov; 7(6):. PubMed ID: 38029326
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
    Lincoln AG; Benton SC; Piggott C; Sheikh SR; Beggs AD; Buckley L; DeSouza B; East JE; Sanders P; Lim M; Sheehan D; Snape K; Hanson H; Greenaway JR; Burn J; Nylander D; Hawkins M; Lalloo F; Green K; Lee TJ; Walker J; Matthews G; Rutherford T; Sasieni P; Monahan KJ
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37668669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoption of faecal immunochemical testing for 2-week-wait colorectal patients during the COVID-19 pandemic: an observational cohort study reporting a new service at a regional centre.
    Maclean W; Limb C; Mackenzie P; Whyte MB; Benton SC; Rockall T; Jourdan I
    Colorectal Dis; 2021 Jul; 23(7):1622-1629. PubMed ID: 33068489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.
    Wassie MM; Young GP; Cock C; Bampton P; Winter JM; Simpson K; Saluja H; Chuang A; Fraser RJ; Symonds EL
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1067-1075. PubMed ID: 35261071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.
    D'Souza N; Hicks G; Benton SC; Abulafi M
    Ann R Coll Surg Engl; 2020 Mar; 102(3):174-179. PubMed ID: 31697171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
    Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.
    von Wagner C; Stoffel S; Freeman M; Laszlo H; Nicholson BD; Sheringham J; Szinay D; Hirst Y
    Br J Gen Pract; 2018 Nov; 68(676):e757-e764. PubMed ID: 30297435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicate and repeat faecal immunochemical tests in symptomatic patients: A systematic review.
    Farkas NG; Fraser CG; Maclean W; Jourdan I; Rockall T; Benton SC
    Ann Clin Biochem; 2023 Jan; 60(1):27-36. PubMed ID: 35394384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential roles of artificial intelligence learning and faecal immunochemical testing for prioritisation of colonoscopy in anaemia.
    Ayling RM; Lewis SJ; Cotter F
    Br J Haematol; 2019 Apr; 185(2):311-316. PubMed ID: 30714125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.
    Parekh M; Fendrick AM; Ladabaum U
    Aliment Pharmacol Ther; 2008 Apr; 27(8):697-712. PubMed ID: 18248653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
    Clark GR; Fraser CG; Strachan JA; Steele RJ
    J Med Screen; 2022 Dec; 29(4):249-254. PubMed ID: 35747907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.
    van Liere ELSA; de Boer NKH; Dekker E; van Leerdam ME; de Meij TGJ; Ramsoekh D
    Aliment Pharmacol Ther; 2022 Apr; 55(7):778-788. PubMed ID: 35181895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer.
    Bowyer HL; Vart G; Kralj-Hans I; Atkin W; Halloran SP; Seaman H; Wardle J; Wagner Cv
    J Med Screen; 2013; 20(3):149-56. PubMed ID: 24045920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
    Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
    BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Screening Program in Northern Portugal: First Findings.
    Monteiro H; Tavares F; Reis J; Ferreira G; Campos MJ; Costa S; Carvalho L; Carvalho J; Pedroto I; Soares J; Henrique R; Bento MJ; Hassan C; Dinis-Ribeiro M
    Acta Med Port; 2022 Mar; 35(3):164-169. PubMed ID: 34283017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening.
    Areia M; Fuccio L; Hassan C; Dekker E; Dias-Pereira A; Dinis-Ribeiro M
    United European Gastroenterol J; 2019 Feb; 7(1):105-113. PubMed ID: 30788122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial.
    Carot L; Castells A; Hernández C; Alvarez-Urturi C; Balaguer F; Lanas A; Cubiella J; Tasende JD; Jover R; Hernandez V; Carballo F; Bujanda L; Quintero E; Andreu M; Bessa X
    United European Gastroenterol J; 2018 Dec; 6(10):1527-1537. PubMed ID: 30574323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.